CVClient

町田 幸大

マチダ コウダイ  (Kodai Machida)

基本情報

所属
兵庫県立大学 大学院 工学研究科 准教授
学位
博士(再生医科学)(2009年3月 鳥取大学)

研究者番号
20553093
J-GLOBAL ID
202001018700160800
researchmap会員ID
R000009667

論文

 34
  • Hayato Ito, Kodai Machida, Yuzo Fujino, Mayuka Hasumi, Soyoka Sakamoto, Yoshitaka Nagai, Hiroaki Imataka, Hideki Taguchi
    2025年5月20日  
    Nucleotide repeat expansions, such as the GGGGCC repeats in C9orf72, associated with C9-ALS, are linked to neurodegenerative diseases. These repeat sequences undergo a non-canonical translation known as repeat-associated non-AUG (RAN) translation. Unlike canonical translation, RAN translation initiates from non-AUG codons and occurs in all reading frames. To identify potential regulators of RAN translation, we employed a bottom-up approach using a human factor-based reconstituted cell-free translation system to recapitulate RAN translation. This approach revealed that omission of either eIF1A or eIF5B enhanced the translation in all reading frames of C9orf72-mediated RAN translation (C9-RAN), suggesting that eIF1A and eIF5B act as repressors of RAN translation. eIF1A and eIF5B are known to contribute to the fidelity of translation initiation. In HEK293T cells, double knockdown of eIF1A and eIF5B further promoted C9-RAN compared to single knockdowns, indicating that these factors regulate C9-RAN through distinct initiation steps. Furthermore, under eIF1A knockdown conditions, the enhancement of RAN translation via the integrated stress response (ISR) was not observed in HEK293T cells, indicating that eIF1A is involved in the ISR-mediated non-AUG translation.
  • Mayuka Hasumi, Hayato Ito, Kodai Machida, Tatsuya Niwa, Tomoya Taminato, Yoshitaka Nagai, Hiroaki Imataka, Hideki Taguchi
    Journal of Biological Chemistry 301(4) 108360-108360 2025年4月  査読有り
  • Kodai Machida, Shotaro Noseda, Seraya Miki, Mayumi Yuasa-Sunagawa, Hiroaki Imataka
    The Journal of Antibiotics 78(5) 288-294 2025年3月26日  筆頭著者責任著者
  • Akihiro Oguro, Takeshi Uemura, Kodai Machida, Kanata Kitajiri, Ayasa Tajima, Takemitsu Furuchi, Gota Kawai, Hiroaki Imataka
    Journal of Biological Chemistry 108251-108251 2025年1月  査読有り
  • Kodai Machida, Rin Tanaka, Seraya Miki, Shotaro Noseda, Mayumi Yuasa-Sunagawa, Hiroaki Imataka
    BioTechniques 76(4) 161-168 2024年4月  査読有り
    Programmed-1 ribosomal frameshifting (-1 PRF) is a translational mechanism adopted by some viruses, including SARS-CoV-2. To find a compound that can inhibit -1 PRF in SARS-CoV-2, we set up a high-throughput screening system using a HeLa cell extract-derived cell-free protein synthesis (CFPS) system. A total of 32,000 compounds were individually incubated with the CFPS system programmed with a -1 PRF-EGFP template. Several compounds were observed to decrease the -1 PRF-driven fluorescence, and one of them had some suppressive effect on -1 PRF of a SARS-CoV-2 genome sequence in transfected cells. Thus the CFPS system can be used as a tool for a high-throughput screening of chemicals.

MISC

 6

講演・口頭発表等

 14

共同研究・競争的資金等の研究課題

 7